181-195 of 239
Barry Davis, MD, PhD
Matthew J. Sorrentino, MD, FACC, FASH
Modernizing Drug Evaluation To Bring Faster Translation
Focus on Future Medicine and GeneticsModernizing Drug Evaluation To Bring Faster Translation
Scott Riccio
Bruce Bloom, DDS, JD
Scott Gottlieb, MD
Antiplatelet Therapy After Drug-Eluting Stent Implantation
Heart MattersAntiplatelet Therapy After Drug-Eluting Stent Implantation
Doug Weaver, MD
Peter Berger, MD
Minimally Invasive Spinal Surgery
Focus on Future Medicine and GeneticsMinimally Invasive Spinal Surgery
Paul Holman, MD
Mark Nolan Hill, MD
Mark DeLegge, MD
William J. Sandborn, MD
Worldwide Challenge: Formulating Drugs for Children
Focus on Global MedicineWorldwide Challenge: Formulating Drugs for Children
Stephen P. Spielberg, MD, PhD
Bill Rutenberg, MD
- advertisement
Do We Already Have the Cure for Type 1 Diabetes?
Focus on DiabetesDo We Already Have the Cure for Type 1 Diabetes?
Denise L. Faustman, MD
Bruce Bloom, DDS, JD
Evolving Treatment of Inflammatory Bowel Disease
GI InsightsEvolving Treatment of Inflammatory Bowel Disease
Jay Goldstein, MD
Richard Fedorak, MD
Factoring Specific Patient Profiles Into Anticoagulation Care
Focus on PharmacyFactoring Specific Patient Profiles Into Anticoagulation Care
Kate Phillips, PharmD
Charles Turck, PharmD, BCPS, BCCCP
Anticoagulant Treatments for Special Patient Populations
Focus on PharmacyAnticoagulant Treatments for Special Patient Populations
Kate Phillips, PharmD
Charles Turck, PharmD, BCPS, BCCCP
Strategies to Overcome Cancer Drug Resistance
Focus on CancerStrategies to Overcome Cancer Drug Resistance
Jeffrey Settleman, PhD
Bruce Bloom, DDS, JD
Central Prescription Processing: A New Trend in Pharmacy?
Focus on PharmacyCentral Prescription Processing: A New Trend in Pharmacy?
Dan Luce, RPh, MBA
Charles Turck, PharmD, BCPS, BCCCP
- advertisement
Your Patient's Drug Bill Keeps Growing: What to Tell Them?
Focus on Public Health PolicyYour Patient's Drug Bill Keeps Growing: What to Tell Them?
Devon Herrick, PhD
Bruce Japsen
Warning: The Risks of Prescribing "Off-Label"
Focus on Public Health PolicyWarning: The Risks of Prescribing "Off-Label"
Mark Herrmann, JD
Larry Kaskel, MD
Preemption: A Physician's Friend or Foe?
Focus on Public Health PolicyPreemption: A Physician's Friend or Foe?
Mark Herrmann, JD
Larry Kaskel, MD